Activated Partial Thromboplastin Time Test Market , by Product type (Consumables, Instruments), by End Use (Clinical Laboratories, Hospitals, Point-of-Care Testing, Others), Regional Analysis (North America, Europe, Asia-Pacific, LAMEA): Global Opportunity Analysis and Industry Forecast, 2019–2026
- RES4072048
- 130 Pages
- February 2020
- Healthcare
Market Description:
The activated partial thromboplastin test (APTT) is a blood test that determines the clotting of blood. The APTT is also called as kaolin cephalin clotting test. The APTT is also used for monitoring the heparin treatment effect. This test evaluates the speed of blood coagulation through two pathways such as common pathway and intrinsic pathway of coagulation.
Market Drivers:
The increase in the demand of thromboplastin test devices for diagnosis and swift growth in the healthcare infrastructure are key drivers for the activated partial thromboplastin time test market growth. The development in the healthcare infrastructure has resulted in the affordability of the APTT tests along with the availability of the test devices. These factors are further expected to boost the growth of the market during the forecast time. In addition, growing prevalence of blood disorders and COPD disease is creating a demand for anticoagulant therapy to control blood clotting, which is further expected to increase the growth of the market.
Market Restraints:
The price associated with test devices and shortage of professionals to conduct the activated partial thromboplastin test are restraining the growth of the market.
Market Opportunities:
Technological improvements in the testing products along with readily available thromboplastin testing devices are projected to create substantial investment opportunities in the activated partial thromboplastin time test market.
Activated Partial Thromboplastin Time Test Market, by Product Type:
The global activated partial thromboplastin time test market is categorized on the basis of product type, technology, application and end use. Based on product type, the market is further classified into consumables and instruments. The consumables segment accounted for the largest market size in the global market and it was valued over $187.1 million in the 2018. The market for instruments is expected to grow with the highest rate of 7.2% CAGR during the estimated period.
Activated Partial Thromboplastin Time Test Market, by End use:
The global market is classified on the basis of end use into clinical laboratories, hospitals, point-of-care testing and others. Among these, hospitals led the highest activated partial thromboplastin time test market share, which was 37.0% in 2018 and is anticipated to generate a revenue of $217.6 million by 2026. The point-of-care testing segment will witness a significant growth during the forecast period.
Activated Partial Thromboplastin Time Test Market, by Region:
Based on region, the global activated partial thromboplastin time test market is analyzed across North America, Europe, Asia-Pacific and LAMEA. Among these, the market for Europe has generated highest activated partial thromboplastin time test market share which was 30.0% in 2018 and it was valued at $105.9 million and is anticipated to continue its growth in the coming years. North America region market held the second highest market size in 2018. The activated partial thromboplastin time test market for Asia-Pacific is anticipated to experience notable growth rate of 7.3% and it is estimated to generate a revenue of $143.1 million by the end of 2026, owing to swift improvements in the healthcare infrastructure.
The major key players in the Activated Partial Thromboplastin Time Test Market:
Takara Bio Inc., Ortho Clinical Diagnostics, Abbott, Beckman Coulter, Inc., bioMérieux, Inc., Siemens Healthcare Private Limited, Bio-Rad Laboratories, Inc., Johnson & Johnson Services, Inc., Hoffmann-La Roche Ltd, ThermoFisher, Danaher, HORIBA, Ltd., and Bio-Rad Laboratories, Inc. are some of the key manufacturers in the activated partial thromboplastin time test market. These manufacturers are adopting strategies such as collaborations & partnerships, joint ventures, geographical expansions and new product launches to gain highest market size in the overall industry.
1.1. Desk Research
1.2. Real time insights and validation
1.3. Forecast model
1.4. Assumptions and forecast parameters
1.4.1. Assumptions
1.4.2. Forecast parameters
1.5. Data sources
1.5.1. Primary
1.5.2. Secondary
2. Executive Summary
2.1. 360° summary
2.2. Product type trends
2.3. End use trends
3. Market Overview
3.1. Market segmentation & definitions
3.2. key takeaways
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Porter’s five forces analysis
3.3.1. Bargaining power of consumers
3.3.2. Bargaining power of suppliers
3.3.3. Threat of new entrants
3.3.4. Threat of substitutes
3.3.5. Competitive rivalry in the market
3.4. Market dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
3.5. Technology landscape
3.6. Regulatory landscape
3.7. Patent landscape
3.8. Strategic overview
4. Activated Partial Thromboplastin Time Test Market, by Product type
4.1. Consumables
4.1.1. Market size and forecast, by region, 2018-2026
4.1.2. Comparative market share analysis, 2018 & 2026
4.2. Instruments
4.2.1. Market size and forecast, by region, 2018-2026
4.2.2. Comparative market share analysis, 2018 & 2026
5. Activated Partial Thromboplastin Time Test Market, by End use
5.1. Clinical laboratories
5.1.1. Market size and forecast, by region, 2018-2026
5.1.2. Comparative market share analysis, 2018 & 2026
5.2. Hospitals
5.2.1. Market size and forecast, by region, 2018-2026
5.2.2. Comparative market share analysis, 2018 & 2026
5.3. Point-of-Care Testing
5.3.1. Market size and forecast, by region, 2018-2026
5.3.2. Comparative market share analysis, 2018 & 2026
5.4. Others
5.4.1. Market size and forecast, by region, 2018-2026
5.4.2. Comparative market share analysis, 2018 & 2026
6. Activated Partial Thromboplastin Time Test Market, by Region
6.1. North America
6.1.1. Market size and forecast, by product type, 2018-2026
6.1.2. Market size and forecast, by end use, 2018-2026
6.1.3. Market size and forecast, by country, 2018-2026
6.1.4. Comparative market share analysis, 2018 & 2026
6.1.5. U.S.
6.1.5.1. Market size and forecast, by product type, 2018-2026
6.1.5.2. Market size and forecast, by end use, 2018-2026
6.1.5.3. Comparative market share analysis, 2018 & 2026
6.1.6. Canada
6.1.6.1. Market size and forecast, by product type, 2018-2026
6.1.6.2. Market size and forecast, by end use, 2018-2026
6.1.6.3. Comparative market share analysis, 2018 & 2026
6.1.7. Mexico
6.1.7.1. Market size and forecast, by product type, 2018-2026
6.1.7.2. Market size and forecast, by end use, 2018-2026
6.1.7.3. Comparative market share analysis, 2018 & 2026
6.2. Europe
6.2.1. Market size and forecast, by product type, 2018-2026
6.2.2. Market size and forecast, by end use, 2018-2026
6.2.3. Market size and forecast, by country, 2018-2026
6.2.4. Comparative market share analysis, 2018 & 2026
6.2.5. UK
6.2.5.1. Market size and forecast, by product type, 2018-2026
6.2.5.2. Market size and forecast, by end use, 2018-2026
6.2.5.3. Comparative market share analysis, 2018 & 2026
6.2.6. Germany
6.2.6.1. Market size and forecast, by product type, 2018-2026
6.2.6.2. Market size and forecast, by end use, 2018-2026
6.2.6.3. Comparative market share analysis, 2018 & 2026
6.2.7. France
6.2.7.1. Market size and forecast, by product type, 2018-2026
6.2.7.2. Market size and forecast, by end use, 2018-2026
6.2.7.3. Comparative market share analysis, 2018 & 2026
6.2.8. Spain
6.2.8.1. Market size and forecast, by product type, 2018-2026
6.2.8.2. Market size and forecast, by end use, 2018-2026
6.2.8.3. Comparative market share analysis, 2018 & 2026
6.2.9. Italy
6.2.9.1. Market size and forecast, by product type, 2018-2026
6.2.9.2. Market size and forecast, by end use, 2018-2026
6.2.9.3. Comparative market share analysis, 2018 & 2026
6.2.10. Rest of Europe
6.2.10.1. Market size and forecast, by product type, 2018-2026
6.2.10.2. Market size and forecast, by end use, 2018-2026
6.2.10.3. Comparative market share analysis, 2018 & 2026
6.3. Asia Pacific
6.3.1. Market size and forecast, by product type, 2018-2026
6.3.2. Market size and forecast, by end use, 2018-2026
6.3.3. Market size and forecast, by country, 2018-2026
6.3.4. Comparative market share analysis, 2018 & 2026
6.3.5. China
6.3.5.1. Market size and forecast, by product type, 2018-2026
6.3.5.2. Market size and forecast, by end use, 2018-2026
6.3.5.3. Comparative market share analysis, 2018 & 2026
6.3.6. Japan
6.3.6.1. Market size and forecast, by product type, 2018-2026
6.3.6.2. Market size and forecast, by end use, 2018-2026
6.3.6.3. Comparative market share analysis, 2018 & 2026
6.3.7. India
6.3.7.1. Market size and forecast, by product type, 2018-2026
6.3.7.2. Market size and forecast, by end use, 2018-2026
6.3.7.3. Comparative market share analysis, 2018 & 2026
6.3.8. Australia
6.3.8.1. Market size and forecast, by product type, 2018-2026
6.3.8.2. Market size and forecast, by end use, 2018-2026
6.3.8.3. Comparative market share analysis, 2018 & 2026
6.3.9. South Korea
6.3.9.1. Market size and forecast, by product type, 2018-2026
6.3.9.2. Market size and forecast, by end use, 2018-2026
6.3.9.3. Comparative market share analysis, 2018 & 2026
6.3.10. Rest of Asia Pacific
6.3.10.1. Market size and forecast, by product type, 2018-2026
6.3.10.2. Market size and forecast, by end use, 2018-2026
6.3.10.3. Comparative market share analysis, 2018 & 2026
6.4. LAMEA
6.4.1. Market size and forecast, by product type, 2018-2026
6.4.2. Market size and forecast, by end use, 2018-2026
6.4.3. Market size and forecast, by country, 2018-2026
6.4.4. Comparative market share analysis, 2018 & 2026
6.4.5. Brazil
6.4.5.1. Market size and forecast, by product type, 2018-2026
6.4.5.2. Market size and forecast, by end use, 2018-2026
6.4.5.3. Comparative market share analysis, 2018 & 2026
6.4.6. Saudi Arabia
6.4.6.1. Market size and forecast, by product type, 2018-2026
6.4.6.2. Market size and forecast, by end use, 2018-2026
6.4.6.3. Comparative market share analysis, 2018 & 2026
6.4.7. South Africa
6.4.7.1. Market size and forecast, by product type, 2018-2026
6.4.7.2. Market size and forecast, by end use, 2018-2026
6.4.7.3. Comparative market share analysis, 2018 & 2026
6.4.8. Rest of LAMEA
6.4.8.1. Market size and forecast, by product type, 2018-2026
6.4.8.2. Market size and forecast, by end use, 2018-2026
6.4.8.3. Comparative market share analysis, 2018 & 2026
7. Company Profiles
7.1. Abbott
7.1.1. Business overview
7.1.2. Financial performance
7.1.3. Product portfolio
7.1.4. Recent strategic moves & developments
7.1.5. SWOT analysis
7.2. Danaher
7.2.1. Business overview
7.2.2. Financial performance
7.2.3. Product portfolio
7.2.4. Recent strategic moves & developments
7.2.5. SWOT analysis
7.3. bioMérieux, Inc.
7.3.1. Business overview
7.3.2. Financial performance
7.3.3. Product portfolio
7.3.4. Recent strategic moves & developments
7.3.5. SWOT analysis
7.4. Bio-Rad Laboratories, Inc.
7.4.1. Business overview
7.4.2. Financial performance
7.4.3. Product portfolio
7.4.4. Recent strategic moves & developments
7.4.5. SWOT analysis
7.5. Siemens Healthcare Private Limited
7.5.1. Business overview
7.5.2. Financial performance
7.5.3. Product portfolio
7.5.4. Recent strategic moves & developments
7.5.5. SWOT analysis
7.6. Hoffmann-La Roche Ltd
7.6.1. Business overview
7.6.2. Financial performance
7.6.3. Product portfolio
7.6.4. Recent strategic moves & developments
7.6.5. SWOT analysis
7.7. Takara Bio Inc.
7.7.1. Business overview
7.7.2. Financial performance
7.7.3. Product portfolio
7.7.4. Recent strategic moves & developments
7.7.5. SWOT analysis
7.8. ThermoFisher
7.8.1. Business overview
7.8.2. Financial performance
7.8.3. Product portfolio
7.8.4. Recent strategic moves & developments
7.8.5. SWOT analysis
7.9. Ortho Clinical Diagnostics
7.9.1. Business overview
7.9.2. Financial performance
7.9.3. Product portfolio
7.9.4. Recent strategic moves & developments
7.9.5. SWOT analysis
7.10. HORIBA, Ltd.
7.10.1. Business overview
7.10.2. Financial performance
7.10.3. Product portfolio
7.10.4. Recent strategic moves & developments
7.10.5. SWOT analysis
7.11. Johnson & Johnson Services, Inc.
7.11.1. Business overview
7.11.2. Financial performance
7.11.3. Product portfolio
7.11.4. Recent strategic moves & developments
7.11.5. SWOT analysis
7.12. Beckman Coulter, Inc.
7.12.1. Business overview
7.12.2. Financial performance
7.12.3. Product portfolio
7.12.4. Recent strategic moves & developments
7.12.5. SWOT analysis
Similar Reports
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
- Publish Date: February 26, 2018
- $5370
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
- Publish Date: May 29, 2018
- $5370
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...
- Publish Date: May 1, 2016
- $5370
